Abstract:Background: This research was designed to investigate patient-reported and doctor-reported reasons for the discontinuation of pharmacological treatment in Chinese patients with major depressive disorder (MDD), which was part of the National Survey on Symptomatology of Depression (NSSD) from 2014 to 2015. Methods: This cross-sectional study included 649 patients who had discontinued antidepressant medications and 711 patients who had remained on them, selected from a group of 3516 candidates who have had at least one depressive episode. Differences in the two groups' sociodemographic factors, clinical characteristics, medication use, and self-reported reasons for drug discontinuation were compared via Student's t-test or chi-square test. Logistic regression analysis was then used to determine the association of all non-subjective dichotomous and ordinal categorical variables, including the additional 63 items of our physician-evaluated symptomatic assessment, with drug compliance. Results: Compared to the spontaneous drug discontinuation (SDD) group, the drug adherence (DA) group had significantly lower rates of the following: family history of mental disease (9.0% vs 13.6%), highest level of education achieved being post-graduate or above (1.6% vs 4.7%), smoking (5.8% vs 9.7%), and other health problems (33.9% vs 42.4%) (p's<0.05). On the other hand, first-episode depression (48.5% vs 21.9%) and taking of mood stabilizer(s) (8.3% vs 5.6%) were higher in the former group than in the latter (p's< 0.05). Logistic Regression Analysis showed that five symptoms, such as depressed mood, were correlated positively with SDD, while another six symptoms, such as psychomotor retardation, were correlated negatively with it. The receiver operating characteristic (ROC) curve of this model yielded an area under the curve (AUC) of 0.701 (95% CI, 0.673-0.729). Notably, there were three main reasons given by patients in the DA group as to why they discontinued their medication(s): (1) concern about long-term side effects (36.1%), (2) no perceived need for taking said medication(s) long-term (34.2%), and (3) believing oneself to have been cured completely (30.0%). Conclusions: The aforementioned factors may affect patient compliance and elicit maladaptive thinking even from patients with good educational backgrounds, increasing the risk of drug discontinuation. Compliance of pharmacological treatment might be improved by increasing clarification and elucidation of different symptom clusters to the patient and combating the main reasons for drug discontinuation.

Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research

Gender Differences in Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with Major Depressive Disorder in China

Prescribing Patterns of Psychotropic Medications and Clinical Features in Patients with Major Depressive Disorder with and Without Comorbid Dysthymia in China

The Impacts of Anhedonia on Brain Functional Alterations in Patients with Major Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study of Regional Homogeneity.

Emotional blunting in patients with depression. Part IV: differences between patient and physician perceptions

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Volume Changes of the Subcortical Limbic Structures in Major Depressive Disorder Patients with and Without Anhedonia.

Apathy associated with antidepressant drugs: a systematic review

Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review

Attenuated Alpha-Gamma Coupling in Emotional Dual Pathways with Right-Amygdala Predicting Ineffective Antidepressant Response

Define and characterize the anhedonia in major depressive disorder: An explorative study

Major depressive disorder associated alterations in the effective connectivity of the face processing network: a systematic review

The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice

Alterations In Emotional And Salience Responses To Positive Stimuli In Major Depressive Disorder

Causes of Drug Discontinuation in Patients with Major Depressive Disorder in China.

Blunted Neural Effects of Perceived Control on Reward Feedback in Major Depressive Disorder.

Emotion Regulating Attentional Control Abnormalities In Major Depressive Disorder: An Event-Related Potential Study

Negative Bias During Early Attentional Engagement in Major Depressive Disorder as Examined Using a Two-Stage Model: High Sensitivity to Sad but Bluntness to Happy Cues

Pharmacological treatment-associated brain structural and functional alterations in major depressive disorder: A narrative review

Emotion Regulation in Current and Remitted Depression: A Systematic Review and Meta-Analysis

Default Mode Network Alterations During Implicit Emotional Faces Processing in First-episode, Treatment-naive Major Depression Patients